Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
AZD5462 | RXFP1 agonist | Probechem Biochemicals
AZD5462 | CAS 2787501-83-9 | AbMole BioScience | AZD5462 Price
化合物 AZD5462 | 2787501-83-9
AZD5462 | RXFP receptor | TargetMol
Chemspace | Analogs to New Biological Tool Compounds | AZD5462
AstraZeneca JMC Reports on RXFP1 Agonist AZD5462
A Phase 1b Randomized Clinical Trial of AZD5462 and Dapagliflozin in ...
Study on the Effects of AZD5462 for Patients with Stable Chronic Heart ...
AZD5462 | Ligand page | IUPHAR/BPS Guide to PHARMACOLOGY
WO2025036918A1 - Compound azd5462 for use in the treatment of heart ...
AstraZeneca leads the development of small molecule RXFP1 agonists
Small Molecule Highlights #24 – April 2024 – Dalriada Drug Discovery
ChemAIRS to Investigate Synthesis Plan for AZD5462: A RXFP1 Agonist for ...
AZD-5462 | Selleck Chemicals
Advancing Isotope Labeling Technologies at AstraZeneca through Academic ...
AZD-5462(AZD-5462) - 药物靶点：RXFP1_在研适应症：慢性心力衰竭，慢性肾病，心脏衰竭_专利_临床_研发
RXFP1受体成心血管新药研发焦点，阿斯利康AZD5462片获批临床_摩熵医药
阿斯利康「抗心衰1类化药」在华申报临床 研究开发 | 华源医药网
阿斯利康口服RXFP1激动剂AZD5462片首次在中国获批临床，拟治疗心力衰竭
RXFP1受体成心血管新药研发焦点，阿斯利康AZD5462片获批临床_摩熵医药(原药融云)
Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric ...
AZD-5462(AZD-5462) - 药物靶点：RXFP1_在研适应症：慢性心力衰竭，心脏衰竭_专利_临床_研发
'Directivo de la semana': Pascal Soriot y AstraZeneca dem...
Mechanistic Understanding of Solid–Solid Phase Transition Based on In ...
How does AstraZeneca's PARP inhibitor differentiate?
Escape Flatland | 近期两个临床分子示例 - 知乎
新药研发，候选化合物筛选时，主要有哪些体外的筛选方法？ - 知乎
